EX-99.3 5 a07-15179_1ex99d3.htm EX-99.3

Exhibit 99.3

BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARY

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION

The following pro forma condensed consolidated financial information is based on the historical financial statements of BIO-key International, Inc. and its subsidiary (the “Company”), including certain pro forma adjustments, and has been prepared to illustrate the pro forma effect of the disposition of the Fire Safety Business segment (the “Fire Business”).

The unaudited pro forma condensed consolidated statements of earnings for the three months ended March 31, 2007 and for the fiscal years ended December 31, 2006 and 2005 assume that the disposition of the Fire Business was effective for the periods indicated. The statements of earnings do not include the gain on the sale or costs associated with the sale. The unaudited pro forma condensed consolidated balance sheet as of March 31, 2007 is presented as if the disposition of the Fire Business had occurred as of that date.

The unaudited pro forma condensed consolidated financial information has been prepared based upon available information and management estimates; actual amounts may differ from these estimated amounts. The unaudited pro forma condensed consolidated financial statements are not necessarily indicative of the financial position or results of operations that might have occurred had the disposition occurred as of the dates stated above. The pro forma adjustments are described in the notes.

The unaudited pro forma condensed consolidated financial information should be read in conjunction with the audited financial statements and notes and related Management’s Discussion and Analysis or Plan of Operation (“MD&A”) included in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006 and unaudited interim financial statements and the related MD&A included in the March 31, 2007 Form 10-QSB for the quarterly period ended March 31, 2007.




BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARY

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET
AS OF MARCH 31, 2007

 

 

Unaudited
Historical

 

Unaudited
Pro Forma
Adjustments

 

Unaudited
Pro Forma
Balance Sheet

 

ASSETS:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

825,791

 

$

2,261,975

(a)

$

3,087,766

 

Receivables, net

 

2,055,863

 

(579,815

)(b)

1,470,812

 

Costs and earnings in excess of billings on uncompleted contracts

 

1,215,045

 

 

1,215,045

 

Inventory

 

30,262

 

(11,716

)(b)

18,546

 

Prepaid expenses

 

121,496

 

(11,041

)(b)

110,455

 

Total current assets

 

4,248,457

 

1,659,403

 

5,970,860

 

Equipment and leasehold improvements, net

 

373,773

 

(41,837

)(b)

331,936

 

Deposits

 

757,017

 

399,450

(a),(b)

1,156,467

 

Intangible assets—less accumulated amortization

 

2,304,863

 

(436,903

)(b)

1,867,960

 

Deferred financing costs, net

 

114,935

 

(114,935

)(d)

 

Goodwill

 

11,389,654

 

(3,552,668

)(b)

7,836,986

 

Total non-current assets

 

14,940,242

 

(3,746,893

)

11,193,349

 

TOTAL ASSETS

 

$

19,188,699

 

$

(2,087,490

)

$

17,101,209

 

LIABILITIES:

 

 

 

 

 

 

 

Current maturities of long-term obligations, net

 

$

2,975,361

 

$

(2,975,361

)(d)

$

 

Accounts payable

 

1,673,863

 

(22,425

)(b)

1,651,438

 

Billings in excess of costs and earnings on uncompleted contracts

 

78,343

 

 

78,343

 

Accrued liabilities

 

4,534,657

 

(511,589

)(a),(c),(e)

4,023,068

 

Deferred rent

 

515,009

 

 

515,009

 

Deferred revenue

 

4,995,990

 

(1,794,312

)(b)

3,201,678

 

Total current liabilities

 

14,773,223

 

(5,303,687

)

9,469,536

 

Warrants and long-term obligations

 

1,091,098

 

(869,632

)(d)

221,466

 

Redeemable preferred stock derivatives

 

80,574

 

 

80,574

 

Deferred rent

 

233,412

 

 

233,412

 

Deferred revenue

 

82,755

 

 

82,755

 

Total non-current liabilities

 

1,487,839

 

(869,632

)

618,207

 

TOTAL LIABILITIES

 

16,261,062

 

(6,173,319

)

10,087,743

 

 

 

 

 

 

 

 

 

Series B redeemable convertible preferred stock, net

 

816,161

 

 

816,161

 

Series C redeemable convertible preferred stock, net

 

5,129,332

 

 

5,129,332

 

 

 

5,945,493

 

 

5,945,493

 

STOCKHOLDERS’ EQUITY/(DEFICIT):

 

 

 

 

 

 

 

Preferred stock

 

3

 

 

3

 

Common stock

 

5,734

 

85

(e)

5,819

 

Additional paid-in capital

 

51,731,578

 

622,679

(e)

52,354,257

 

Accumulated deficit

 

(54,755,171

)

3,463,065

(f)

(51,280,390

)

TOTAL STOCKHOLDERS’ EQUITY/(DEFICIT)

 

(3,017,856

)

4,085,829

 

1,067,973

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY/(DEFICIT)

 

$

19,188,699

 

$

(2,087,490

)

$

17,101,209

 

 




BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARY

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF EARNINGS
FOR THE THREE MONTHS ENDED MARCH 31, 2007

 

 

Unaudited
Historical

 

Unaudited
Proforma
Adjustments

 

Unaudited
Proforma
Income
Statement

 

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

Services

 

$

2,595,433

 

$

(720,257

)(g)

$

1,875,176

 

License fees and other

 

1,277,063

 

(436,999

)(g)

840,064

 

 

 

3,872,496

 

(1,157,256

)

2,715,240

 

Costs and other expenses

 

 

 

 

 

 

 

Cost of services

 

624,306

 

(162,107

)(g)

462,199

 

Cost of license fees and other

 

71,794

 

(40,565

)(g)

31,229

 

 

 

696,100

 

(202,672

)

493,428

 

Gross Profit

 

3,176,396

 

(954,584

)

2,221,812

 

 

 

 

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

Selling, general and administrative

 

2,686,013

 

(123,546

)(g)

2,562,467

 

Research, development and engineering

 

1,687,706

 

(305,801

)(g)

1,381,905

 

 

 

4,373,719

 

(429,347

)

3,944,372

 

Operating loss

 

(1,197,323

)

(525,237

)

(1,722,560

)

Other income (deductions)

 

 

 

 

 

 

 

Derivative and warrant fair value adjustments

 

829,369

 

(512,912

)(j)

316,457

 

Interest expense

 

(538,517

)

458,875

(h)

(79,642

)

Other

 

(5,902

)

 

(5,902

)

 

 

284,950

 

(54,037

)

230,913

 

NET LOSS

 

$

(912,373

)

$

(579,274

)

$

(1,491,647

)

 

 

 

 

 

 

 

 

Basic and Diluted Loss to Common Shareholders:

 

 

 

 

 

 

 

Net loss

 

$

(912,373

)

$

(579,274

)

$

(1,491,647

)

Convertible preferred stock dividends and accretion

 

(471,390

)

)

(471,390

)

Net loss attributable to common shareholders

 

$

(1,383,763

)

$

(579,274

)

$

(1,963,037

)

 

 

 

 

 

 

 

 

Net Loss Per Share:

 

 

 

 

 

 

 

Basic

 

$

(0.02

)

$

(0.01

)

$

(0.03

)

Diluted

 

$

(0.02

)

$

(0.01

)

$

(0.03

)

 

 

 

 

 

 

 

 

Weighted Average Shares Outstanding:

 

 

 

 

 

 

 

Basic

 

56,634,523

 

57,484,523

(k)

57,484,523

 

Diluted

 

56,634,523

 

57,484,523

(k)

57,484,523

 

 




BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARY

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF EARNINGS
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2006

 

 

Historical

 

Unaudited
Proforma
Adjustments

 

Unaudited
Proforma
Income
Statement

 

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

Services

 

$

10,949,895

 

$

(2,801,513

)(g)

$

8,148,382

 

License fees and other

 

4,243,730

 

(1,104,941

)(g)

3,138,789

 

 

 

15,193,625

 

(3,906,454

)

11,287,171

 

Costs and other expenses

 

 

 

 

 

 

 

Cost of services

 

2,673,823

 

(456,635

)(g)

2,217,188

 

Cost of license fees and other

 

722,883

 

(70,032

)(g)

652,851

 

 

 

3,396,706

 

(526,667

)

2,870,039

 

Gross Profit

 

11,796,919

 

(3,379,787

)

8,417,132

 

 

 

 

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

Selling, general and administrative

 

10,311,017

 

(384,705

)(g)

9,926,312

 

Research, development and engineering

 

6,514,353

 

(1,001,609

)(g)

5,512,744

 

 

 

16,825,370

 

(1,386,314

)

15,439,056

 

Operating loss

 

(5,028,451

)

(1,993,473

)

(7,021,924

)

Other income (deductions)

 

 

 

 

 

 

 

Derivative and warrant fair value adjustments

 

7,542,666

 

(2,253,195

)(j)

5,289,471

 

Interest expense

 

(5,730,712

)

1,871,331

(h)

(3,859,381

)

Loss on extinguishment of debt

 

(7,815,717

)

2,979,627

(i)

(4,836,090

)

Other

 

(48,637

)

 

(48,637

)

 

 

(6,052,400

)

2,597,763

 

(3,454,637

)

NET LOSS

 

$

(11,080,851

)

$

604,290

 

$

(10,476,561

)

 

 

 

 

 

 

 

 

Basic and Diluted Loss to Common Shareholders:

 

 

 

 

 

 

 

Net loss

 

$

(11,808,851

)

$

604,290

 

$

(10,476,561

)

Convertible preferred stock dividends and accretion

 

(1,042,069

)

 

(1,042,069

)

Net loss attributable to common shareholders

 

$

(12,122,920

)

$

604,290

 

$

(11,518,630

)

 

 

 

 

 

 

 

 

Net Loss Per Share:

 

 

 

 

 

 

 

Basic

 

$

(0.24

)

$

0.01

 

$

(0.23

)

Diluted

 

$

(0.24

)

$

0.01

 

$

(0.23

)

 

 

 

 

 

 

 

 

Weighted Average Shares Outstanding:

 

 

 

 

 

 

 

Basic

 

50,232,961

 

51,082,961

(k)

51,082,961

 

Diluted

 

50,232,961

 

51,082,961

(k)

51,082,961

 

 




BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARY

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF EARNINGS
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2005

 

 

Historical

 

Unaudited
Proforma
Adjustments

 

Unaudited
Proforma
Income
Statement

 

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

Services

 

$

10,861,649

 

$

(2,814,616

)(g)

$

8,047,033

 

License fees and other

 

3,364,446

 

(406,470

)(g)

2,957,976

 

 

 

14,226,095

 

(3,221,086

)

11,005,009

 

Costs and other expenses

 

 

 

 

 

 

 

Cost of services

 

2,906,142

 

(381,048

)(g)

2,525,094

 

Cost of license fees and other

 

937,491

 

(81,286

)(g)

856,205

 

 

 

3,843,633

 

(462,334

)

3,381,299

 

Gross Profit

 

10,382,462

 

(2,758,752

)

7,623,710

 

 

 

 

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

Selling, general and administrative

 

11,824,609

 

(373,330

)(g)

11,451,279

 

Research, development and engineering

 

6,846,035

 

(577,979

)(g)

6,268,056

 

 

 

18,670,644

 

(951,309

)

17,719,335

 

Operating loss

 

(8,288,182

)

 

 

(10,095,625

)

Other income (deductions)

 

 

 

 

 

 

 

Derivative and warrant fair value adjustments

 

9,154,951

 

(2,829,604

)(j)

6,325,347

 

Interest income

 

35,958

 

 

35,958

 

Interest expense

 

(4,521,344

)

1,645,062

(h)

(2,876,282

)

Loss on sale of marketable securities

 

(20,000

)

 

(20,000

)

Other

 

(34,767

)

 

(34,767

)

 

 

4,614,798

 

(1,184,542

)

3,430,256

 

NET LOSS

 

$

(3,673,384

)

$

(2,991,985

)

$

(6,665,369

)

 

 

 

 

 

 

 

 

Basic and Diluted Loss to Common Shareholders:

 

 

 

 

 

 

 

Net loss

 

$

(3,673,384

)

$

(2,991,985

)

$

(6,665,369

)

Convertible preferred stock dividends and accretion

 

(313,517

)

 

(313,517

)

Net loss attributable to common shareholders

 

$

(3,986,901

)

$

(2,991,985

)

$

(6,978,886

)

 

 

 

 

 

 

 

 

Net Loss Per Share:

 

 

 

 

 

 

 

Basic

 

$

(0.09

)

$

(0.07

)

$

(0.16

)

Diluted

 

$

(0.12

)

$

(0.06

)

$

(0.18

)

 

 

 

 

 

 

 

 

Weighted Average Shares Outstanding:

 

 

 

 

 

 

 

Basic

 

44,787,807

 

45,637,807

(k)

45,637,807

 

Diluted

 

52,046,303

 

49,711,711

(k)

49,711,711

 

 




BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.     BASIS OF PRESENTATION

The accompanying unaudited pro forma condensed consolidated financial statements give effect to the pro forma adjustments necessary to reflect the disposition of the Fire Business as if the disposition was effective for the periods presented in the pro forma statements of earnings and as of March 31, 2007 in the pro forma balance sheet.

The Company’s historical amounts represent our condensed balance sheet and statements of operations derived from our Annual report on Form 10-KSB for the year ended December 31, 2006 and Quarterly report on Form 10-QSB for the period ended March 31, 2007.

Pro forma statements of earnings disclose earnings from continuing operations before nonrecurring charges and therefore exclude historical earnings and losses from discontinued operations for the fiscal years ended December 31, 2006 and 2005, and the quarterly period ended March 31, 2007.

2.     PRO FORMA ADJUSTMENTS

The unaudited pro forma condensed consolidated statements of earnings and balance sheet reflect the effect of the following pro forma adjustments:

a)                   Assumes the receipt of approximately $7.0 million in cash from Zoll on sale of the Fire Business, reduced by repayment of all convertible debt, accrued interest, and escrow holdback.

b)                  The elimination of assets and liabilities associated with the Fire Business included in the Company’s historical condensed consolidated financial statements. The Company allocated a percentage of the net book value of amortizable intangible assets and goodwill to the Fire business in a manner consistent with the method used during the Company’s annual FAS 142 and FAS 144 analysis.

c)                   Amount includes the accrual for estimated costs incurred in connection with the sale of the Fire Business.

d)                  Convertible debt was repaid as part of the transaction, therefore the associated balance of unamortized convertible debt discounts, embedded derivatives, and deferred finance charges were written off. The remaining balance listed in pro forma statement represents freestanding warrants.

e)                   The Company’s common stock and additional paid in capital balances increased due to the issuance of 850,000 shares of restricted stock in exchange for the balance of accrued default interest, as part of the transaction.

f)                     The Company’s accumulated deficit was reduced as a result of an estimated after-tax gain of approximately $4.0 million on the disposal of the Fire Business, and increased by writing off the balance of deferred finance charges, unamortized debt discounts on convertible debt and embedded derivatives on convertible debt.

g)                  Reduction of revenue and expenses are the result of the disposition of the Fire Business. These amounts do not consider an allocation of general corporate overhead costs not specifically related to the Fire Business and therefore, selling, general and administrative expenses do not reflect any potential reductions in corporate costs in response to this change in the Company.

h)                  Amounts represent reduced interest and associated expenses on convertible debt for all periods presented, from the use of $4.3 million of cash proceeds to retire a portion of the Company’s outstanding debt. Historical interest and associated expenses on convertible debt were reduced by the percentage of debt retired for




each pro forma period presented.

i)                      Reduction of loss on extinguishment of debt for the 2006 fiscal year, by the percentage of convertible debt retired.

j)                      Reduction of the fair value adjustment for embedded derivatives on convertible debt for all periods presented by the percentage of convertible debt retired.

k)                   Weighted average shares outstanding was reduced through the elimination of convertible debt (2005 diluted shares only) and increased through the issuance of 850,000 shares of restricted common stock (all periods).